DescriptionJunmaikang® is a biosimilar of adalimumab, a fully human monoclonal antibody targeting TNF??, approved by China’s NMPA (approval number S20220008) . Manufactured by Suzhou Zhonghe Biomed Tech Co., Ltd., it mirrors the therapeutic action of Humira®, and is widely used in research exploring autoimmune pathways, inflammation, and immune modulation.Available as a single-use 0.8?mL prefilled syringe containing 40?mg adalimumab, it supports in vitro and in vivo laboratory research—such as cytokine inhibition assays, arthritis models, immune cell signaling pathways, and TNF?? neutralization studies. Contents hide 1 Adalimumab Injection Product Specifications 2 Adalimumab Injection Mechanism & Research Applications 3 Adalimumab Injection Observed Effects & Preclinical Notes 4 Safety & Handling Guidelines 5 Research Use Disclaimer Adalimumab Injection Product SpecificationsParameterDetailsProduct NameAdalimumab Injection (Junmaikang)Generic NameAdalimumab (TNF?? Monoclonal Antibody Biosimilar)CAS Number331731?18?1Molecular FormulaProtein (monoclonal antibody ~148?kDa)Dosage FormPrefilled syringeStrength40?mg in 0.8?mLPackaging1 syringe per boxApproval NumberS20220008 (China NMPA)Product Code86981823000043ManufacturerSuzhou Zhonghe Biomed Tech Co., Ltd.Intended UseLaboratory research onlyStorage ConditionsRefrigerate at 2–8?°C; protect from lightBarcode(Not specified)Adalimumab Injection Mechanism & Research ApplicationsAdalimumab (Junmaikang) functions by binding to TNF??, blocking its interaction with cell receptors, thereby inhibiting inflammatory signaling cascades. As an NMPA-approved biosimilar, it’s suitable for:TNF?? neutralization assaysAutoimmune disease models (arthritis, colitis)Inflammatory cytokine modulation studiesImmunology and cell signaling researchComparative analysis with reference adalimumabAdalimumab Injection Observed Effects & Preclinical NotesWhile primarily a research agent, adalimumab has shown:In vivo reduction of TNF?? levels and inflammatory markersModulation of immune cell functionMinimal immunogenic responses in validated animal modelsResearchers should monitor dose responses and manage biosafety per institutional guidelines.Safety & Handling GuidelinesUse Restriction: Laboratory research only — not for human or veterinary usePPE Required: Gloves, lab coat, safety gogglesStorage: Keep refrigerated at 2–8?°C; avoid freezing and light exposureDisposal: Dispose as biohazardous material per institutional protocolsResearch Use DisclaimerThis product is strictly for laboratory research use only. It is not intended for human or veterinary treatment, clinical diagnosis, or use. Misuse may result in serious legal and health consequences. Handle according to biosafety and institutional regulations.
